Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence.
- DOI
- 10.1080/17576180.2025.2489917
- Published
- 2025 Apr
- Container
- Bioanalysis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17576180.2025.2489917,
title = {Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence.},
author = {Javid S and Ramya K and Gulzar Ahmed M and Zahiya N and Thansheefa N and Anas AK and Mahfeela F and Reeha and Sha F and Sultana R},
year = {2025},
journal = {Bioanalysis},
doi = {10.1080/17576180.2025.2489917},
url = {https://doi.org/10.1080/17576180.2025.2489917}
}RIS
TY - JOUR TI - Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence. AU - Javid S AU - Ramya K AU - Gulzar Ahmed M AU - Zahiya N AU - Thansheefa N AU - Anas AK AU - Mahfeela F AU - Reeha AU - Sha F AU - Sultana R PY - 2025 JO - Bioanalysis DO - 10.1080/17576180.2025.2489917 UR - https://doi.org/10.1080/17576180.2025.2489917 ER -
APA
S, J., K, R., M, G. A., N, Z., N, T., AK, A., F, M., Reeha, F, S., & R, S. (2025). Bioanalysis of antihypertensive drugs by LC-MS: a fleeting look at the regulatory guidelines and artificial intelligence.. Bioanalysis. https://doi.org/10.1080/17576180.2025.2489917
Source records
- pubmed · retrieved 2026-11-10T14:20:42.789Z